Scientific Advisory Board

The Scientific Advisory Board (SAB) is a volunteer panel of experts which reviews funding applications to determine scientific excellence and relevance to Parkinson’s disease, providing the highest quality of objective adjudication.

  • Dr. Ron Postuma, Chair, Associate Professor of Neurology and Neurosurgery, Faculty of Medicine, McGill University; Staff neurologist, Montreal General Hospital, Researcher at the Research Institute of the McGill University Health Centre (MUHC) and at Sacré Coeur Hospital
  • Dr. Silke Appel-Cresswell, Assistant Professor, Medicine/Neurology, University of British Columbia; Clinician Scientist, Pacific Parkinson’s Research Centre and Djavad Mowafghian Centre for Brain Health
  • Dr. Frédéric Calon, Professor, Department of Pharmacy, Université Laval
  • Dr. Robert Chen, Professor of Medicine (Neurology), University of Toronto; Senior Scientist, Krembil Research Institute; Senior Scientist
  • Dr. Bin Hu, Professor, Departments of Clinical Neurosciences, Cell Biology & Anatomy, University of Calgary
  • Dr. Wayne Martin, Professor, Division of Neurology, Movement Disorders Program, University of Alberta, Kaye Edmonton Clinic
  • Dr. Mario Masellis, Associate Scientist, Sunnybrook Health Institute; Assistant Professor, Neurology, Department of Medicine, University of Toronto
  • Dr. Janis M. Miyasaki, Assistant Professor, Division of Neurology, WMC University of Alberta
  • Dr. Abid Oueslati, Assistant Professor, Faculty of Medicine, Université Laval
  • Dr. Caroline Paquette, Assistant Professor, Department of Kinesiology and Physical Education, McGill University
  • Dr. Abbas Sadikot, Neurosurgeon, Montreal Neurological Institute, McGill University
  • Dr. Antonio Strafella, Senior Scientist, Research Imaging Centre at CAMH; Professor, Department of Medicine’s Division of Neurology at the University Health Network (UHN); Senior Scientist, Division of Brain Imaging & Behaviour Systems-Neuroscience, Toronto Western Research Institute (TWRI);, Adjunct Professor, McGill
  • Dr. Michael G. Schlossmacher, Senior Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Neurologist, Division of Neurology, Department of Medicine, The Ottawa Hospital; Associate Professor of Medicine (Neurology), and Director of the MD/PhD Program, Faculty of Medicine, University of Ottawa
  • Dr. Anurag Tandon, Researcher, Centre for Research in Neurodegenerative Diseases, University of Toronto
  • Dr. Louis-Eric Trudeau, Professor, Department of Pharmacology, Faculty of Medicine, University of Montreal
  • Dr. Jean-François Trempe, Assistant Professor, Department of Pharmacology & Therapeutics, McGill University
  • Dr. Joel Watts, Assistant Professor, Department of Biochemistry, University of Toronto; Principal Investigator, Tanz Centre for Research in Neurodegenerative Diseases (CRND)